Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)

ClinicalTrials.gov ID: NCT01830920

Public ClinicalTrials.gov record NCT01830920. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 7:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Parallel-Group, Randomized, Double Blind, Adaptive Study Investigating the Safety and Efficacy of THR-184 in Patients at Increased Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether THR-184 when administered around the time of cardiac surgery that requires cardiopulmonary bypass can prevent or ameliorate the development of acute kidney injury.

Study identification

NCT ID
NCT01830920
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Thrasos Innovation, Inc.
Industry
Enrollment
452 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2013 (Type not available)
Primary completion
Sep 2015 (Actual)
Completion
Sep 2015 (Actual)
Last update posted
Apr 20, 2017

2013 – 2015

United States locations

U.S. sites
31
U.S. states
18
U.S. cities
29
Facility City State ZIP Site status
University of Alabama-Birmingham Birmingham Alabama 35294 —
University of Southern California Los Angeles California 90033 —
Stanford University Stanford California 94305 —
Harbor - University of California Los Angeles Medical Center Torrance California 90503 —
Danbury Hospital Danbury Connecticut 06810 —
River City Clinical Research Jacksonville Florida 32207 —
University of Chicago Chicago Illinois 60637 —
Advocate Christ Medical Center Oak Lawn Illinois 60453 —
Indiana Ohio Heart Fort Wayne Indiana 46804 —
Indiana Heart-St. Vincent Medical Group Indianapolis Indiana 46290 —
Maine Medical Center Portland Maine 04102 —
John Hopkins University Baltimore Maryland 21287 —
Suburban Hospital Bethesda Maryland 20814 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Baystate Medical Center Springfield Massachusetts 01199 —
Cardiac and Vascular Research Center of Northern Michigan Petoskey Michigan 49770 —
Covenant Medical Center Saginaw Michigan 48602 —
Washington University St Louis Missouri 63110 —
St. Joseph's Regional Medical Center Paterson New Jersey 07503 —
St. Peter's Hospital Albany New York 12208 —
Columbia University New York New York 10032 —
Duke University Medical Center Durham North Carolina 27710 —
Durham VA Medical Center Durham North Carolina 27710 —
Lindner Research Center-Christ Hospital Cincinnati Ohio 45219 —
The Ohio State University Medical Center Columbus Ohio 43210 —
Erlanger Health System Chattanooga Tennessee 37404 —
Memorial Hospital Chattanooga Tennessee 37404 —
Vanderbilt University Medical Center Nashville Tennessee 37212 —
Baylor University Medical Center, Soltero Cardiovascular Research Center Dallas Texas 75226 —
University of Texas, Houston Houston Texas 77030 —
Cardiothoracic Surgical Associates Richmond Virginia 23225 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01830920, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2017 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01830920 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →